AdAlta Competitors and Similar CompaniesClear all
Teva Pharmaceuticals's competitors and similar companies include Biogen and Samumed.
 Biogen Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases. |  Samumed Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation. | ||
Founding Date | Founding Date 1901 | Founding Date 1978 | Founding Date 2008 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Petah Tikva, IL HQ Villa Adelina, AR Macquarie Park, AU Minsk, BY Antwerpen, BE Sao Paulo, BR Dupnica, BG see more | Locations Cambridge, US HQ Vicente López, AR Macquarie Park, AU Wien, AT Machelen, BE São Paul, BR Toronto, CA see more | Locations San Diego, US HQ San Diego, US |
Employees | Employees 37,000 | Employees 7,605 | Employees 1701% increase |
Valuation ($) | Valuation ($) 20.8 b | Valuation ($) 26.7 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $17.3b (FY, 2025) | Revenue (est.) $9.9b (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $8.3b (FY, 2025) | Cost of goods $2.4b (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $8.9b (FY, 2025) | Gross profit $7.5b (FY, 2025) | Gross profit N/A |
Net income | Net income $1.4b (FY, 2025) | Net income $1.3b (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 358m | Total funding raised N/A | Total funding raised $ 438m |
For sources of this data, please see the company profile
View Company Profiles
Biogen
HQ
Cambridge, US
Employees
7,605
Biogen (formerly known as Biogen Idec) is a biopharmaceutical company that develops and delivers therapies for neurological and neurodegenerative diseases.
View companySamumed
HQ
San Diego, US
Employees
170↑ 1% increase
Samumed is a pharmaceutical platform company focused on advancing regenerative medicine and oncology applications through research and innovation.
View company